KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Receivables: 2019-2025

  • Aurora Cannabis' Receivables fell 11.23% to $31.5 million in Q1 2025 from the same period last year, while for Mar 2025 it was $126.8 million, marking a year-over-year decrease of 5.09%. This contributed to the annual value of $31.5 million for FY2025, which is 11.23% down from last year.
  • Aurora Cannabis' Receivables amounted to $31.5 million in Q1 2025, which was down 11.23% from $35.5 million recorded in Q1 2024.
  • Aurora Cannabis' Receivables' 5-year high stood at $38.3 million during Q2 2022, with a 5-year trough of $27.6 million in Q2 2023.
  • Its 3-year average for Receivables is $31.7 million, with a median of $31.8 million in 2023.
  • Its Receivables has fluctuated over the past 5 years, first dropped by 27.94% in 2023, then rose by 10.56% in 2024.
  • Quarterly analysis of 4 years shows Aurora Cannabis' Receivables stood at $38.3 million in 2022, then declined by 27.94% to $27.6 million in 2023, then climbed by 10.56% to $35.5 million in 2024, then declined by 11.23% to $31.5 million in 2025.
  • Its Receivables was $31.5 million in Q1 2025, compared to $35.5 million in Q1 2024 and $27.6 million in Q2 2023.